VRTX
Vertex Pharmaceuticals Incorporated
NMS
$426.01
+0.92
(+0.22%)
Pullback · -0.92σ
Quarterly financials
last 6 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $2.99B | $2.59B | $1.14B | $1.03B | $1.29B | 86.8% | 38.1% | 34.5% |
| 2025-12-31 | $3.19B | $2.72B | $1.13B | $1.19B | $348.6M | 85.4% | 35.4% | 37.3% |
| 2025-09-30 | $3.08B | $2.66B | $1.24B | $1.08B | $1.14B | 86.5% | 40.3% | 35.2% |
| 2025-06-30 | $2.96B | $2.56B | $1.15B | $1.03B | $927.4M | 86.3% | 38.9% | 34.8% |
| 2025-03-31 | $2.77B | $2.41B | $1.03B | $646.3M | $778.2M | 86.9% | 37.2% | 23.3% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |